Allyl Isothiocyanate Protects Acetaminophen-Induced Liver Injury via NRF2 Activation by Decreasing Spontaneous Degradation in Hepatocyte. 2020

Min Woo Kim, and Ju-Hee Kang, and Hyun Jin Jung, and Se Yong Park, and Thu Han Le Phan, and Hee Namgung, and Seung-Yong Seo, and Yeo Sung Yoon, and Seung Hyun Oh
Department of Anatomy and Cell Biology, College of Veterinary Medicine, Seoul National University, Seoul 08826, Korea.

Acetaminophen (APAP) is one of the most frequently prescribed analgesic and anti-pyretic drugs. However, APAP-induced hepatotoxicity is a major cause of acute liver failure globally. While the therapeutic dose is safe, an overdose of APAP produces an excess of the toxic metabolite N-acetyl-p-benzoquinone imine (NAPQI), subsequently resulting in hepatotoxicity. Allyl isothiocyanate (AITC), a bioactive molecule in cruciferous plants, is reported to exert various biological effects, including anti-inflammatory, anti-cancer, and anti-microbial effects. Notably, AITC is known for activating nuclear factor erythroid 2-related factor 2 (NRF2), but there is limited evidence supporting the beneficial effects on hepatocytes and liver, where AITC is mainly metabolized. We applied a mouse model in the current study to investigate whether AITC protects the liver against APAP-induced injury, wherein we observed the protective effects of AITC. Furthermore, NRF2 nuclear translocation and the increase of target genes by AITC treatment were confirmed by in vitro experiments. APAP-induced cell damage was attenuated by AITC via an NRF2-dependent manner, and rapid NRF2 activation by AITC was attributed to the elevation of NRF2 stability by decreasing its spontaneous degradation. Moreover, liver tissues from our mouse experiment revealed that AITC increases the expression of heme oxygenase-1 (HO-1), an NRF2 target gene, confirming the potential of AITC as a hepatoprotective agent that induces NRF2 activation. Taken together, our results indicate the potential of AITC as a natural-product-derived NRF2 activator targeting the liver.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000082 Acetaminophen Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage. Acetamidophenol,Hydroxyacetanilide,Paracetamol,APAP,Acamol,Acephen,Acetaco,Acetominophen,Algotropyl,Anacin-3,Datril,N-(4-Hydroxyphenyl)acetanilide,N-Acetyl-p-aminophenol,Panadol,Tylenol,p-Acetamidophenol,p-Hydroxyacetanilide,Anacin 3,Anacin3
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D056486 Chemical and Drug Induced Liver Injury A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment. Drug-Induced Liver Injury,Liver Injury, Drug-Induced,Acute Liver Injury, Drug-Induced,Chemically-Induced Liver Toxicity,Drug-Induced Acute Liver Injury,Drug-Induced Liver Disease,Hepatitis, Drug-Induced,Hepatitis, Toxic,Liver Injury, Drug-Induced, Acute,Toxic Hepatitis,Acute Liver Injury, Drug Induced,Chemically Induced Liver Toxicity,Chemically-Induced Liver Toxicities,Disease, Drug-Induced Liver,Diseases, Drug-Induced Liver,Drug Induced Acute Liver Injury,Drug Induced Liver Disease,Drug Induced Liver Injury,Drug-Induced Hepatitides,Drug-Induced Hepatitis,Drug-Induced Liver Diseases,Drug-Induced Liver Injuries,Hepatitides, Drug-Induced,Hepatitides, Toxic,Hepatitis, Drug Induced,Injuries, Drug-Induced Liver,Injury, Drug-Induced Liver,Liver Disease, Drug-Induced,Liver Diseases, Drug-Induced,Liver Injuries, Drug-Induced,Liver Injury, Drug Induced,Liver Toxicities, Chemically-Induced,Liver Toxicity, Chemically-Induced,Toxic Hepatitides,Toxicities, Chemically-Induced Liver,Toxicity, Chemically-Induced Liver
D017879 Isothiocyanates Organic compounds with the general formula R-NCS.
D018712 Analgesics, Non-Narcotic A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. Non Opioid Analgesic,Non-Opioid Analgesic,Nonopioid Analgesic,Nonopioid Analgesics,Analgesics, Nonnarcotic,Analgesics, Nonopioid,Non-Opioid Analgesics,Analgesic, Non Opioid,Analgesic, Non-Opioid,Analgesic, Nonopioid,Analgesics, Non Narcotic,Analgesics, Non-Opioid,Non Opioid Analgesics,Non-Narcotic Analgesics,Nonnarcotic Analgesics,Opioid Analgesic, Non
D022781 Hepatocytes The main structural component of the LIVER. They are specialized EPITHELIAL CELLS that are organized into interconnected plates called lobules. Hepatic Cells,Cell, Hepatic,Cells, Hepatic,Hepatic Cell,Hepatocyte

Related Publications

Min Woo Kim, and Ju-Hee Kang, and Hyun Jin Jung, and Se Yong Park, and Thu Han Le Phan, and Hee Namgung, and Seung-Yong Seo, and Yeo Sung Yoon, and Seung Hyun Oh
February 2023, Food & function,
Min Woo Kim, and Ju-Hee Kang, and Hyun Jin Jung, and Se Yong Park, and Thu Han Le Phan, and Hee Namgung, and Seung-Yong Seo, and Yeo Sung Yoon, and Seung Hyun Oh
January 2022, International journal of biological sciences,
Min Woo Kim, and Ju-Hee Kang, and Hyun Jin Jung, and Se Yong Park, and Thu Han Le Phan, and Hee Namgung, and Seung-Yong Seo, and Yeo Sung Yoon, and Seung Hyun Oh
April 2024, Molecular medicine reports,
Min Woo Kim, and Ju-Hee Kang, and Hyun Jin Jung, and Se Yong Park, and Thu Han Le Phan, and Hee Namgung, and Seung-Yong Seo, and Yeo Sung Yoon, and Seung Hyun Oh
December 2023, Toxicological sciences : an official journal of the Society of Toxicology,
Min Woo Kim, and Ju-Hee Kang, and Hyun Jin Jung, and Se Yong Park, and Thu Han Le Phan, and Hee Namgung, and Seung-Yong Seo, and Yeo Sung Yoon, and Seung Hyun Oh
September 2013, Yao xue xue bao = Acta pharmaceutica Sinica,
Min Woo Kim, and Ju-Hee Kang, and Hyun Jin Jung, and Se Yong Park, and Thu Han Le Phan, and Hee Namgung, and Seung-Yong Seo, and Yeo Sung Yoon, and Seung Hyun Oh
January 2021, American journal of translational research,
Min Woo Kim, and Ju-Hee Kang, and Hyun Jin Jung, and Se Yong Park, and Thu Han Le Phan, and Hee Namgung, and Seung-Yong Seo, and Yeo Sung Yoon, and Seung Hyun Oh
June 2012, Toxicological sciences : an official journal of the Society of Toxicology,
Min Woo Kim, and Ju-Hee Kang, and Hyun Jin Jung, and Se Yong Park, and Thu Han Le Phan, and Hee Namgung, and Seung-Yong Seo, and Yeo Sung Yoon, and Seung Hyun Oh
October 2022, Ecotoxicology and environmental safety,
Min Woo Kim, and Ju-Hee Kang, and Hyun Jin Jung, and Se Yong Park, and Thu Han Le Phan, and Hee Namgung, and Seung-Yong Seo, and Yeo Sung Yoon, and Seung Hyun Oh
June 2022, Environmental toxicology,
Min Woo Kim, and Ju-Hee Kang, and Hyun Jin Jung, and Se Yong Park, and Thu Han Le Phan, and Hee Namgung, and Seung-Yong Seo, and Yeo Sung Yoon, and Seung Hyun Oh
October 2018, Regulatory toxicology and pharmacology : RTP,
Copied contents to your clipboard!